Prediction of Cytochrome P450-Mediated Hepatic Drug Clearance in Neonates, Infants and Children Sven Björkman Current Opinion 30 September 2012 Pages: 1 - 11
Significance of the Minor Cytochrome P450 3A Isoforms Ann K. Daly Review Article 30 September 2012 Pages: 13 - 31
Mass Balance Studies, with a Focus on Anticancer Drugs Jan H. BeumerJos H. BeijnenJan H. M. Schellens Review Article 30 September 2012 Pages: 33 - 58
Population Pharmacokinetics of Tacrolimus in Whole Blood and Plasma in Asian Liver Transplant Patients Wai Johnn SamLai San ThamPaul C. Ho Original Research Article 30 September 2012 Pages: 59 - 75
Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Ximelagatran in Young Healthy Japanese Men Linda C. WernevikPer NyströmUlf G. Eriksson Original Research Article 30 September 2012 Pages: 77 - 84
Comparable Pharmacokinetics and Pharmacodynamics of Melagatran in Japanese and Caucasian Volunteers after Oral Administration of the Direct Thrombin Inhibitor Ximelagatran Linda C. WernevikPer NyströmUlf G. Eriksson Original Research Article 30 September 2012 Pages: 85 - 94
Compliance-Guided Therapy Alexia BlesiusSylvie ChabaudPatrice Nony Original Research Article 30 September 2012 Pages: 95 - 104
‘Hedged’ Prescribing for Partially Compliant Patients John UrquhartBernard Vrijens Commentary 30 September 2012 Pages: 105 - 108